# ABX advanced biochemical compounds

Source: https://nuclide.cc/companies/abx-advanced-biochemical-compounds/  
Nuclide record `abx-advanced-biochemical-compounds` (Company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

ABX is a German maker of the precursors and kits behind PET imaging tracers, including PSMA agents for prostate cancer, and sponsors the trials that register them.

## Summary

ABX advanced biochemical compounds, based in Radeberg near Dresden, manufactures radiopharmaceutical precursors, cold kits and labelling chemistry used to produce PET tracers, among them PSMA-directed agents for prostate cancer imaging developed with the German Cancer Research Center. It acts as lead sponsor of phase 3 diagnostic trials registered on ClinicalTrials.gov.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: ABX advanced biochemical compounds GmbH; ABX GmbH; ABX
- Tags: ctgov-sponsor
- HQ: Radeberg
- Type: pharma
- Website: https://www.abx.de

## Sources

- Official website: https://www.abx.de
- ClinicalTrials.gov: trials led by ABX advanced biochemical compounds: https://clinicaltrials.gov/search?lead=ABX%20advanced%20biochemical%20compounds

## Connected records

- indications: [Prostate cancer](https://nuclide.cc/indications/prostate/)
- technologies: [PSMA PET](https://nuclide.cc/technologies/psma-pet/)
- drugs: [PSMA-1007 F-18](https://nuclide.cc/drugs/psma-1007-f18/)
- trials: [Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer](https://nuclide.cc/trials/nct06122584/)

---
JSON: https://nuclide.cc/api/v1/entities/abx-advanced-biochemical-compounds.json